bis(1-aminoethylidene-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]azanium);1-aminoethylidene-[3-[7-methyl-6-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]azanium;N-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[7-methyl-6-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine

C140H176N36O8S4+12 — CID 161416318

IUPACbis(1-aminoethylidene-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]azanium);1-aminoethylidene-[3-[7-methyl-6-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]azanium;N-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[7-methyl-6-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine
SMILESC/C(N)=[NH+]\CCC[n+]1cnc(C=C2Sc3ccccc3N2C)c2c1ncn2C.CN1C(=Cc2cc[n+](CCCNC3=[NH+]CCN3)cc2)Oc2ccccc21.CN1C(=Cc2nc[n+](CCCNC3=[NH+]CCN3)c3ncn(C)c23)Oc2ccccc21.COc1cc2c(C=C3Sc4ccccc4N3C)nc(CCCC/[NH+]=C(\C)N)[n+](C)c2cc1OC.COc1cc2c(C=C3Sc4ccccc4N3C)nc(CCCC/[NH+]=C(\C)N)[n+](C)c2cc1OC.COc1cc2c(C=C3Sc4ccccc4N3C)nc(CCCCNC3=[NH+]CCN3)[n+](C)c2cc1OC
InChIInChI=1S/C27H33N6O2S.2C26H32N5O2S.C21H25N8O.C20H24N7S.C20H24N5O/c1-32-21-17-23(35-4)22(34-3)15-18(21)19(16-26-33(2)20-9-5-6-10-24(20)36-26)31-25(32)11-7-8-12-28-27-29-13-14-30-27;2*1-17(27)28-13-9-8-12-25-29-19(15-26-31(3)20-10-6-7-11-24(20)34-26)18-14-22(32-4)23(33-5)16-21(18)30(25)2;1-27-13-26-20-19(27)15(12-18-28(2)16-6-3-4-7-17(16)30-18)25-14-29(20)11-5-8-22-21-23-9-10-24-21;1-14(21)22-9-6-10-27-13-23-15(19-20(27)24-12-25(19)2)11-18-26(3)16-7-4-5-8-17(16)28-18;1-24-17-5-2-3-6-18(17)26-19(24)15-16-7-13-25(14-8-16)12-4-9-21-20-22-10-11-23-20/h5-6,9-10,15-17H,7-8,11-14H2,1-4H3,(H2,28,29,30);2*6-7,10-11,14-16H,8-9,12-13H2,1-5H3,(H2,27,28);3-4,6-7,12-14H,5,8-11H2,1-2H3,(H2,22,23,24);4-5,7-8,11-13H,6,9-10H2,1-3H3,(H2,21,22);2-3,5-8,13-15H,4,9-12H2,1H3,(H2,21,22,23)/q6*+1/p+6
InChIKeyVWDBDBMLSZMKMH-UHFFFAOYSA-T
MW2619.46 g/mol
LogP5.93
Rot. Bonds39

About bis(1-aminoethylidene-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]azanium);1-aminoethylidene-[3-[7-methyl-6-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]azanium;N-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[7-methyl-6-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine

bis(1-aminoethylidene-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]azanium);1-aminoethylidene-[3-[7-methyl-6-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]azanium;N-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[7-methyl-6-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine (PubChem CID 161416318) has the molecular formula C140H176N36O8S4+12 and a molecular weight of 2619.46 g/mol. Its IUPAC name is bis(1-aminoethylidene-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]azanium);1-aminoethylidene-[3-[7-methyl-6-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]azanium;N-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[7-methyl-6-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine.

Molecular Properties

Compound Namebis(1-aminoethylidene-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]azanium);1-aminoethylidene-[3-[7-methyl-6-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]azanium;N-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[7-methyl-6-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine
PubChem CID161416318
Molecular FormulaC140H176N36O8S4+12
Molecular Weight2619.46 g/mol
Exact Mass2617.33
IUPAC Namebis(1-aminoethylidene-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]azanium);1-aminoethylidene-[3-[7-methyl-6-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]azanium;N-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[7-methyl-6-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine
SMILESC/C(N)=[NH+]\CCC[n+]1cnc(C=C2Sc3ccccc3N2C)c2c1ncn2C.CN1C(=Cc2cc[n+](CCCNC3=[NH+]CCN3)cc2)Oc2ccccc21.CN1C(=Cc2nc[n+](CCCNC3=[NH+]CCN3)c3ncn(C)c23)Oc2ccccc21.COc1cc2c(C=C3Sc4ccccc4N3C)nc(CCCC/[NH+]=C(\C)N)[n+](C)c2cc1OC.COc1cc2c(C=C3Sc4ccccc4N3C)nc(CCCC/[NH+]=C(\C)N)[n+](C)c2cc1OC.COc1cc2c(C=C3Sc4ccccc4N3C)nc(CCCCNC3=[NH+]CCN3)[n+](C)c2cc1OC
InChIInChI=1S/C27H33N6O2S.2C26H32N5O2S.C21H25N8O.C20H24N7S.C20H24N5O/c1-32-21-17-23(35-4)22(34-3)15-18(21)19(16-26-33(2)20-9-5-6-10-24(20)36-26)31-25(32)11-7-8-12-28-27-29-13-14-30-27;2*1-17(27)28-13-9-8-12-25-29-19(15-26-31(3)20-10-6-7-11-24(20)34-26)18-14-22(32-4)23(33-5)16-21(18)30(25)2;1-27-13-26-20-19(27)15(12-18-28(2)16-6-3-4-7-17(16)30-18)25-14-29(20)11-5-8-22-21-23-9-10-24-21;1-14(21)22-9-6-10-27-13-23-15(19-20(27)24-12-25(19)2)11-18-26(3)16-7-4-5-8-17(16)28-18;1-24-17-5-2-3-6-18(17)26-19(24)15-16-7-13-25(14-8-16)12-4-9-21-20-22-10-11-23-20/h5-6,9-10,15-17H,7-8,11-14H2,1-4H3,(H2,28,29,30);2*6-7,10-11,14-16H,8-9,12-13H2,1-5H3,(H2,27,28);3-4,6-7,12-14H,5,8-11H2,1-2H3,(H2,22,23,24);4-5,7-8,11-13H,6,9-10H2,1-3H3,(H2,21,22);2-3,5-8,13-15H,4,9-12H2,1H3,(H2,21,22,23)/q6*+1/p+6
InChIKeyVWDBDBMLSZMKMH-UHFFFAOYSA-T
XLogP5.93
TPSA450.71 Ų
H-Bond Donors15
H-Bond Acceptors33
Rotatable Bonds39
Heavy Atoms188
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002619.46
LogP ≤ 55.93
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'dyes5A(27)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze bis(1-aminoethylidene-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]azanium);1-aminoethylidene-[3-[7-methyl-6-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]azanium;N-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[7-methyl-6-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of bis(1-aminoethylidene-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]azanium);1-aminoethylidene-[3-[7-methyl-6-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]azanium;N-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[7-methyl-6-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine?
The IUPAC name of bis(1-aminoethylidene-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]azanium);1-aminoethylidene-[3-[7-methyl-6-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]azanium;N-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[7-methyl-6-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine (CID 161416318) is bis(1-aminoethylidene-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]azanium);1-aminoethylidene-[3-[7-methyl-6-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]azanium;N-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[7-methyl-6-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine.
What is the SMILES notation for bis(1-aminoethylidene-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]azanium);1-aminoethylidene-[3-[7-methyl-6-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]azanium;N-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[7-methyl-6-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine?
The canonical SMILES for bis(1-aminoethylidene-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]azanium);1-aminoethylidene-[3-[7-methyl-6-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]azanium;N-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[7-methyl-6-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine is C/C(N)=[NH+]\CCC[n+]1cnc(C=C2Sc3ccccc3N2C)c2c1ncn2C.CN1C(=Cc2cc[n+](CCCNC3=[NH+]CCN3)cc2)Oc2ccccc21.CN1C(=Cc2nc[n+](CCCNC3=[NH+]CCN3)c3ncn(C)c23)Oc2ccccc21.COc1cc2c(C=C3Sc4ccccc4N3C)nc(CCCC/[NH+]=C(\C)N)[n+](C)c2cc1OC.COc1cc2c(C=C3Sc4ccccc4N3C)nc(CCCC/[NH+]=C(\C)N)[n+](C)c2cc1OC.COc1cc2c(C=C3Sc4ccccc4N3C)nc(CCCCNC3=[NH+]CCN3)[n+](C)c2cc1OC.
What is the InChIKey of bis(1-aminoethylidene-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]azanium);1-aminoethylidene-[3-[7-methyl-6-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]azanium;N-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[7-methyl-6-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine?
The InChIKey is VWDBDBMLSZMKMH-UHFFFAOYSA-T. The full InChI is InChI=1S/C27H33N6O2S.2C26H32N5O2S.C21H25N8O.C20H24N7S.C20H24N5O/c1-32-21-17-23(35-4)22(34-3)15-18(21)19(16-26-33(2)20-9-5-6-10-24(20)36-26)31-25(32)11-7-8-12-28-27-29-13-14-30-27;2*1-17(27)28-13-9-8-12-25-29-19(15-26-31(3)20-10-6-7-11-24(20)34-26)18-14-22(32-4)23(33-5)16-21(18)30(25)2;1-27-13-26-20-19(27)15(12-18-28(2)16-6-3-4-7-17(16)30-18)25-14-29(20)11-5-8-22-21-23-9-10-24-21;1-14(21)22-9-6-10-27-13-23-15(19-20(27)24-12-25(19)2)11-18-26(3)16-7-4-5-8-17(16)28-18;1-24-17-5-2-3-6-18(17)26-19(24)15-16-7-13-25(14-8-16)12-4-9-21-20-22-10-11-23-20/h5-6,9-10,15-17H,7-8,11-14H2,1-4H3,(H2,28,29,30);2*6-7,10-11,14-16H,8-9,12-13H2,1-5H3,(H2,27,28);3-4,6-7,12-14H,5,8-11H2,1-2H3,(H2,22,23,24);4-5,7-8,11-13H,6,9-10H2,1-3H3,(H2,21,22);2-3,5-8,13-15H,4,9-12H2,1H3,(H2,21,22,23)/q6*+1/p+6.
What are the key properties of bis(1-aminoethylidene-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]azanium);1-aminoethylidene-[3-[7-methyl-6-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]azanium;N-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[7-methyl-6-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine?
bis(1-aminoethylidene-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]azanium);1-aminoethylidene-[3-[7-methyl-6-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]azanium;N-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[7-methyl-6-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine has a molecular weight of 2619.46 g/mol, XLogP of 5.93, 39 rotatable bonds, 15 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for bis(1-aminoethylidene-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]azanium);1-aminoethylidene-[3-[7-methyl-6-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]azanium;N-[4-[6,7-dimethoxy-1-methyl-4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinazolin-1-ium-2-yl]butyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine;N-[3-[7-methyl-6-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]purin-3-ium-3-yl]propyl]-4,5-dihydro-1H-imidazol-3-ium-2-amine is sourced from PubChem (CID 161416318), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).